Cargando…
The miR-200 family in ovarian cancer
Ovarian cancer (OC) is the most lethal gynecological malignancy. Its insidious nature, manifesting with little to no symptoms until the disease progresses to metastasis, along with a wide diversity of histological subtypes and corresponding clinical behavior, poses significant therapeutic challenges...
Autores principales: | Koutsaki, Maria, Libra, Massimo, Spandidos, Demetrios A., Zaravinos, Apostolos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630443/ https://www.ncbi.nlm.nih.gov/pubmed/29029543 http://dx.doi.org/10.18632/oncotarget.18343 |
Ejemplares similares
-
The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2015) -
Role of miR‑200 family in brain metastases: A systematic review
por: Fotakopoulos, George, et al.
Publicado: (2023) -
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016) -
MiR-200c and HuR in ovarian cancer
por: Prislei, Silvia, et al.
Publicado: (2013) -
The miR-200 family: multiple effects on gliomas
por: Peng, Lilei, et al.
Publicado: (2018)